Theratechnologies (TSX:TH) Research & Development : C$22.5 Mil (TTM As of Feb. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Theratechnologies Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Theratechnologies's Research & Development for the three months ended in Feb. 2025 was C$4.2 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2025 was C$22.5 Mil.

Theratechnologies Research & Development Historical Data

The historical data trend for Theratechnologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Research & Development Chart

Theratechnologies Annual Data

Trend

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Nov24

Research & Development

Get a 7-Day Free Trial

23.56

35.53

49.71

41.63

23.72

Theratechnologies Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Research & Development	Get a 7-Day Free Trial															5.07	6.46	3.57	8.22	4.25

Theratechnologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$22.5 Mil.

Theratechnologies (TSX:TH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Theratechnologies Research & Development Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

THTX:USA TQ80:Germany

Address

2015, rue Peel, 11th Floor, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Executives

Dale Weil	Director
Joseph Arena	Director
Philippe Dubuc	Senior Officer
Gérald A. Lacoste	Director
Paul Lévesque	Senior Officer
Andrew Molson	Director
Dawn Svoronos	Director
John Leasure	Senior Officer
Alain Trudeau	Director
Sheila Frame	Director
Gary Peter Littlejohn	Director
Marie-noël Colussi	Senior Officer
Jovan Antunovic	Senior Officer
Christian Marsolais	Senior Officer
Jocelyn Lafond	Senior Officer